Eli Lilly Archives | Be Korea-savvy

Samsung Biologics Inks COVID-19 Drug Manufacturing Deal with Eli Lilly

SEOUL, Nov. 17 (Korea Bizwire) — South Korean pharmaceutical firm Samsung Biologics Co. said Tuesday it has signed a long-term agreement with U.S. pharmaceutical firm Eli Lilly and Company to manufacture a novel coronavirus-neutralizing antibody. Under the contract manufacturing organization (CMO) agreement, Samsung Biologics will provide Eli Lilly’s investigational neutralizing antibody for the treatment of [...]

Market Value of Bio Stocks Surges on Growth Hopes

SEOUL, March 26 (Korea Bizwire) — The market value of bio and health care shares listed on the South Korean stock markets surpassed 30 trillion won (US$27.22 billion) for the first time as investors pinned high hopes on their future growth, the bourse main operator Korea Exchange (KRX) said Thursday. The combined market cap of the [...]